Macquarie lifts F&P Healthcare price target by 7.3%

Macquarie lifts F&P Healthcare price target by 7.3%
Rebecca Howard
By Rebecca Howard May 23 (BusinessDesk) - Macquarie Group lifted its 12-month target price on Fisher & Paykel Healthcare by 7.3 percent and kept its 'outperform' rating after the company's full-year revenue growth beat expectations and as a weaker New Zealand dollar weighs in the exporter's favour.  The Australian investment house has a 12-month target price of $11, up from $10.25. The stock recently unchanged at $10.10.  F&P Healthcare yesterday posted an 18 percent gain in full-year profit, meeting guidance with record annual sales,...